Resumo Fundamento O SAGE foi desenvolvido para identificar hipertensos com chance de velocidade de onda de pulso (VOP) aumentada. Até o momento, as publicações do escore foram em hipertensos. Objetivo Verificar a capacidade do SAGE de identificar os normotensos ou pré-hipertensos com chance de aumento da VOP. Métodos Transversal retrospectivo, incluiu exames de normotensos e pré-hipertensos que realizaram a medida central da pressão arterial e apresentavam os parâmetros para o cálculo do escore. Para cada pontuação do escore, foi analisada a sensibilidade, especificidade, valor preditivo positivo e negativo utilizando como ponto de corte para o diagnóstico positivo VOP ≥ 10m/s, ≥9,08 m/s (percentil 75) e ≥7,30 m/s (percentil 50). Um valor de p<0,05 foi adotado como estatisticamente significante. Resultados A amostra foi de 100 participantes normotensos ou pré-hipertensos, com média (DP) de 52,64 (14,94) anos e VOP mediana de 7,30 m/s (6,03 – 9,08). O SAGE apresentou correlação com idade (r=0,938, p<0,001), glicemia (r=0,366, p<0,001) e taxa de filtração de glomerular (r=-0,658, p<0,001). A área sob a curva ROC foi de 0,968 (p<0,001) para VOP≥10 m/s, 0,977 (p<0,001) para VOP≥9,08 m/s e 0,967 (p<0,001) para VOP≥7,30 m/s. O escore 7 apresentou especificidade de 95,40% e sensibilidade de 100% para VOP≥10 m/s. O ponto de corte seria cinco para VOP≥9,08 m/s (s=96,00%, e= 94,70%), e dois para VOP≥7,30 m/s. Conclusão O SAGE foi capaz de identificar indivíduos com maior chance de apresentar rigidez arterial, utilizando diferentes pontos de corte de VOP. Entretanto, o desenvolvimento de um escore específico para normontensos e pré-hipertensos faz-se necessário. (VOP aumentada momento préhipertensos pré retrospectivo 10ms ms 10m s m 10m/s 908 9 08 ≥9,0 percentil 75 730 30 ≥7,3 50. 50 . 50) p005 p 0 05 p<0,0 significante 10 préhipertensos, hipertensos, DP (DP 5264 52 64 52,6 14,94 1494 14 94 (14,94 7,3 6,03 603 6 03 (6,0 9,08. 9,08 9,08) r=0,938, r0938 r 938 (r=0,938 p<0,001, p0001 p<0,001 , 001 r=0,366, r0366 366 (r=0,366 r=0,658, r0658 r= 0,658, 658 (r=-0,658 p<0,001. 0968 968 0,96 (p<0,001 VOP10 VOP≥1 0977 977 0,97 VOP908 VOP≥9,0 0967 967 VOP730 VOP≥7,3 9540 95 40 95,40 s=96,00%, s9600 96 00 (s=96,00% 94,70%, 9470 94,70% 70 94,70%) Entretanto fazse faz se necessário 90 ≥9, 73 3 ≥7, 5 p00 p<0, 1 526 52, 14,9 149 (14,9 7, 6,0 60 (6, 9,0 r=0,938 r093 93 (r=0,93 p000 p<0,00 r=0,366 r036 36 (r=0,36 r=0,658 r065 0658 0,658 65 (r=-0,65 096 0,9 (p<0,00 VOP1 VOP≥ 097 97 VOP90 VOP≥9, VOP73 VOP≥7, 954 4 95,4 s=96,00% s960 (s=96,00 947 94,70 ≥9 ≥7 p0 p<0 14, (14, 6, (6 9, r=0,93 r09 (r=0,9 r=0,36 r03 (r=0,3 r=0,65 r06 065 0,65 (r=-0,6 09 0, (p<0,0 VOP9 VOP≥9 VOP7 VOP≥7 95, s=96,00 s96 (s=96,0 94,7 p< (14 ( r=0,9 r0 (r=0, r=0,3 r=0,6 06 0,6 (r=-0, (p<0, s=96,0 s9 (s=96, 94, (1 r=0, (r=0 (r=-0 (p<0 s=96, (s=96 r=0 (r= (r=- (p< s=96 (s=9 (r (p s=9 (s= s= (s
Abstract Background The SAGE score was developed to detect individuals at risk for increased pulse wave velocity (PWV). So far, studies have been focused on hypertensive patients. Objective To assess the ability of the score to detect non-hypertensive and pre-hypertensive patients at risk for increased PWV. Methods Retrospective cross-sectional study of analysis of central blood pressure data and calculation of the SAGE score of non-hypertensive and pre-hypertensive patients. Each score point was analyzed for sensitivity, specificity, positive and negative predictive values, using the cut-off point for positive diagnosis a PVW ≥ 10m/s, ≥9.08 m/s (75thpercentile) and ≥7.30 m/s (50thpercentile). A p<0.05 was considered statistically significant. Results The sample was composed of 100 normotensive and pre-hypertensive individuals, with mean age of 52.64 ± 14.94 years and median PWV of 7.30 m/s (6.03 – 9.08). The SAGE score was correlated with age (r=0.938, p<0.001), glycemia (r=0.366, p<0.001) and glomerular filtration rate (r=-0.658, p<0.001). The area under the ROC curve was 0.968 (p<0.001) for PWV ≥ 10 m/s, 0.977 (p<0.001) for PWV ≥ 9.08 m/s and 0.967 (p<0.001) for PWV ≥ 7.30 m/s. The score 7 showed a specificity of 95.40% and sensitivity of 100% for PWV≥10 m/s. The cut-off point would be of five for a PWV≥9.08 m/s (sensitivity =96.00%, specificity = 94.70%), and two for a PWV ≥ 7.30 m/s. Conclusion The SAGE score could identify individuals at higher risk of arterial stiffness, using different PWV cutoff points. However, the development of a specific score for normotensive and pre-hypertensive subjects is needed. . (PWV) far nonhypertensive non prehypertensive pre crosssectional cross sectional values cut off 10ms ms 10m s m 10m/s 908 9 08 ≥9.0 75thpercentile thpercentile (75thpercentile 730 30 ≥7.3 50thpercentile. 50thpercentile (50thpercentile) p005 p 0 05 p<0.0 significant 5264 52 64 52.6 1494 14 94 14.9 7.3 6.03 603 6 03 (6.0 9.08. 9.08) r=0.938, r0938 r 938 (r=0.938 p<0.001, p0001 p<0.001 , 001 r=0.366, r0366 366 (r=0.366 r=0.658, r0658 r= 0.658, 658 (r=-0.658 p<0.001. 0968 968 0.96 (p<0.001 1 0977 977 0.97 9.0 0967 967 9540 95 40 95.40 PWV10 PWV≥1 PWV908 PWV≥9.0 9600 96 00 =96.00% 94.70%, 9470 94.70% 70 94.70%) stiffness points However needed (PWV 90 ≥9. 73 3 ≥7. (50thpercentile p00 p<0. 526 5 52. 149 14. 7. 6.0 60 (6. r=0.938 r093 93 (r=0.93 p000 p<0.00 r=0.366 r036 36 (r=0.36 r=0.658 r065 0658 0.658 65 (r=-0.65 096 0.9 (p<0.00 097 97 9. 954 4 95.4 PWV1 PWV≥ PWV90 PWV≥9. 960 =96.00 947 94.70 ≥9 ≥7 p0 p<0 6. (6 r=0.93 r09 (r=0.9 r=0.36 r03 (r=0.3 r=0.65 r06 065 0.65 (r=-0.6 09 0. (p<0.0 95. PWV9 PWV≥9 =96.0 94.7 p< ( r=0.9 r0 (r=0. r=0.3 r=0.6 06 0.6 (r=-0. (p<0. =96. 94. r=0. (r=0 (r=-0 (p<0 =96 r=0 (r= (r=- (p< =9 (r (p